Articles

Elon Musk’s X.AI wins $6 billion in private funding as the latest unicorn to avoid an IPO

X.Ai, a competitor to ChatGPT parent OpenAI, disclosed a large round of funding without the need to become a public company.

UnitedHealth shooting sparks security fears for execs but fixes are expensive and complicated

Security company execs have seen a dramatic increase in inquiries for services after the murder of Brian Thompson.

Palantir’s fiery stock surge has been polarizing. Here’s what the CEO thinks.

Palantir shares are up 1,100% off their lows, with skeptics voicing concern about the valuation.

Why Powell and the Fed might pause interest-rate cuts in December

Some say November’s jobs data support holding monetary policy steady.

Is the U.S. jobs market weaker than it looks? Here are some hints.

The U.S. has averaged a respectable 173,000 new jobs a month since September, in a sign the labor market is still pretty healthy — but warning signs are flashing.

How do I make sure my retirement accounts go to my wife, and then my kids, when I die?

Planning and proper documentation is required if your wishes are to be carried out

The stock market’s ‘fear gauge’ is trading at lows. Why retail investors should take note.

The  Cboe Volatility Index hasn’t been this low in months.

Tesla’s stock climbs to highest price in years. Here’s why it can keep going.

Tesla’s stock rallies toward a more than 2 1/2-year high, and BofA laid out reasons why it can rise even further.

UnitedHealth’s stock is down 10% this week as exec’s killing leads to criticism of claims treatment

Shares of health insurers and managed-care companies were falling across the board.

I spent months fighting an unfair medical bill. Here’s how I won.

Consumer protections exist, but it can take a lot of time, patience and determination to fight a health insurer, and not everyone prevails.

10 fast-growing software stocks to watch in 2025, including the runaway Palantir

A deeper looks shows that despite the growth, some software stocks have gotten ahead of analysts’ price targets.

What’s in store for the U.S. housing market in 2025?

Also: The aging bull market for stocks, the UnitedHealth aftermath and advice from the Moneyist.
1 226 227 228 229 230 1,983